A randomised controlled clinical trial to assess the benefits of a telecare tool delivered prior to the initial hearing assessment.pdf (1.95 MB)
A randomised controlled clinical trial to assess the benefits of a telecare tool delivered prior to the initial hearing assessment
journal contribution
posted on 2023-05-05, 15:53 authored by David MaidmentDavid Maidment, E Heffernan, MA FergusonObjective. To assess the benefits of the Ida Institute’s Why improve my hearing? Telecare Tool used before the initial hearing assessment appointment.
Design. A prospective, single-blind randomised clinical trial with two arms: (i) Why improve my hearing? Telecare Tool intervention, and (ii) standard care control.
Study sample. Adults with hearing loss were recruited from two Audiology Services within the United Kingdom’s publicly-funded National Health Service. Of 461 individuals assessed for eligibility, 57 were eligible to participate.
Results. Measure of Audiologic Rehabilitation Self-efficacy for Hearing Aids (primary outcome) scores did not differ between groups from baseline to post-assessment (Mean change [Δ]= -2.28; 95% confidence interval [CI]= -6.70, 2.15, p= .307) and 10-weeks follow-up (Mean Δ= - 2.69; 95% CI= -9.52, 4.15, p= .434). However, Short Form Patient Activation Measure scores significantly improved in the intervention group compared to the control group from baseline to post-assessment (Mean Δ= -6.06, 95% CI= -11.31, -0.82, p= .024, ES= .61) and 10-weeks follow-up (Mean Δ= -9.87, 95% CI= -15.34, -4.40, p= .001, ES= -.97).
Conclusions. This study demonstrates that while a patient-centred telecare intervention completed before management decisions may not improve an individual’s self-efficacy to manage their hearing loss, it can lead to improvements in readiness.
Funding
Ida Institute
NIHR Nottingham Biomedical Research Centre
History
School
- Sport, Exercise and Health Sciences
Published in
International Journal of AudiologyVolume
62Issue
5Pages
400-409Publisher
Taylor & FrancisVersion
- VoR (Version of Record)
Rights holder
© The AuthorsPublisher statement
This is an Open Access Article. It is published by Taylor & Francis under the Creative Commons Attribution 4.0 International Licence (CC BY). Full details of this licence are available at: https://creativecommons.org/licenses/by/4.0/Acceptance date
2022-03-22Publication date
2022-04-18Copyright date
2022ISSN
1499-2027eISSN
1708-8186Publisher version
Language
- en
Depositor
Dr David Maidment. Deposit date: 24 March 2022Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC